XML 52 R43.htm IDEA: XBRL DOCUMENT v3.23.1

Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Reconciliation of Basic and Diluted Earnings (Loss) Per Share

The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December 31, 2022, 2021 and 2020:

In millions, except per share amounts			2022						2021						2020
Numerator for earnings per share calculation:
Income from continuing operations			$	4,327					$	7,989					$	7,201
Net (income) loss attributable to noncontrolling interests			(16)						12						(13)
Income from continuing operations attributable to CVS Health			$	4,311					$	8,001					$	7,188
Denominator for earnings per share calculation:
Weighted average shares, basic			1,312						1,319						1,309
Restricted stock units and performance stock units			6						6						4
Stock options and SARs			5						4						1
Weighted average shares, diluted			1,323						1,329						1,314
Earnings per share from continuing operations:
Basic			$	3.29					$	6.07					$	5.49
Diluted			$	3.26					$	6.02					$	5.47

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration